Clinical trial
Treatment of Post-Traumatic Brain Injury (TBI) Depression
NCT00233103 · Icahn School of Medicine at Mount Sinai, Other · Completed
Key facts
| NCT number | NCT00233103 |
|---|---|
| Title | Treatment of Post-Traumatic Brain Injury (TBI) Depression |
| Official title | Treatment of Post-TBI Depression |
| Lead sponsor | Icahn School of Medicine at Mount Sinai, Other |
| Collaborators | U.S. Department of Education U.S. Fed |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Depression |
| Intervention type | Drug |
| Interventions | Sertraline, Placebo |
| Enrollment | 52 |
| Start date | Jun 1, 2003 |
| Primary completion | Sep 1, 2008 |
| Completion | Sep 1, 2008 |
| First posted | Oct 5, 2005 |
| Last update posted | Nov 13, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: